# Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cardiovascular-outcomes-and-risks-after-initiation-of-a-sodium-glucose/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jacob A. Udell,Žhong Yuan,Toni Rush,Nicholas Sicignano,Michael S. Galitz,Norman Rosenthal |
| Citations | 230 |
| DOI | 10.1161/circulationaha.117.031227 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1161/circulationaha.117.031227 |
| OpenAlex ID | https://openalex.org/W2768451744 |
| PMID | 29133607 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Žhong Yuan](https://scholariq.org/researchers/zhong-yuan/)

## Paper journal

- [Circulation](https://scholariq.org/journals/circulation/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.